General Information of Drug-Metabolizing Enzyme (DME) (ID: DET64RG)

DME Name Pancreatic alpha-amylase (AMY2A)
Synonyms Alpha-D-glucan glucanohydrolase; 1,4-alpha-D-glucan glucanohydrolase; AMY2A; PA
Gene Name AMY2A
UniProt ID
AMYP_HUMAN
INTEDE ID
DME0148
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Gene ID
279
EC Number EC: 3.2.1.1
Hydrolases
Glycosylase
O/S-glycosyl compound glycosidase
EC: 3.2.1.1
Lineage Species: Homo sapiens
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Sequence
MKFFLLLFTIGFCWAQYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPP
NENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGN
AVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGL
LDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAG
SKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWG
FVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWP
RQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQP
FTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGI
KIYVSDDGKAHFSISNSAEDPFIAIHAESKL
Function This enzyme hydrolyzes 1,4-alpha-glucoside bonds in oligosaccharides and polysaccharides, and thus catalyze the first step in digestion of dietary starch and glycogen.
KEGG Pathway
Carbohydrate digestion and absorption (hsa04973 )
Metabolic pathways (hsa01100 )
Pancreatic secretion (hsa04972 )
Starch and sucrose metabolism (hsa00500 )
Reactome Pathway
Digestion of dietary carbohydrate (R-HSA-189085 )

Molecular Interaction Atlas (MIA) of This DME

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DME
1 Approved Drug(s) Metabolized by This DME
Drug Name Drug ID Indication ICD 11 Highest Status REF
Icodextrin DM648X9 Kidney disease GC2Z Approved [8]

The Drug Therapeutic Target (DTT) Role of This DME

DME DTT Name Pancreatic alpha-amylase (AMY2A) DTT Info
DME DTT Type Clinical trial
2 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pancrecarb DMOML9Q Pancreatic malfunction DC30-DC3Z NDA filed [1]
Liprotamase DMNF4UH Cystic fibrosis CA25 Phase 3 [2]
11 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
4,6-Dideoxy-4-Amino-Alpha-D-Glucose DMBZIG7 Discovery agent N.A. Investigative [3]
5-Hydroxymethyl-Chonduritol DMZHVRW Discovery agent N.A. Investigative [3]
6-Deoxy-Alpha-D-Glucose DM9HBY5 Discovery agent N.A. Investigative [3]
Acanthus ilicifolius Linn DMZDFRI Discovery agent N.A. Investigative [4]
Acarbose Derived Hexasaccharide DMS9COH Discovery agent N.A. Investigative [3]
Alpha-acarviosinyl-(1-->7)-3-alpha-D-glucopyranosylpropen DMHV14R Discovery agent N.A. Investigative [5]
Alpha-acarviosinyl-(1-->9)-3-alpha-D-glucopyranosylpropen DM4IXUQ Discovery agent N.A. Investigative [5]
Beta-D-Glucose DM5IHYP Discovery agent N.A. Investigative [3]
Hydroxycitric acid DMY0A9E Discovery agent N.A. Investigative [6]
Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam DMMY542 Discovery agent N.A. Investigative [7]
Pyroglutamic Acid DMROZUA Discovery agent N.A. Investigative [3]
⏷ Show the Full List of 11 Investigative Drug(s)

References

1 Clinical pipeline report, company report or official report of Digestive Care.
2 Clinical pipeline report, company report or official report of Anthera Pharmaceuticals.
3 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
4 Four acarviosin-containing oligosaccharides identified from Streptomyces coelicoflavus ZG0656 are potent inhibitors of alpha-amylase. Carbohydr Res. 2008 Apr 7;343(5):882-92.
5 Enzymatic synthesis of a selective inhibitor for alpha-glucosidases: alpha-acarviosinyl-(1-->9)-3-alpha-D-glucopyranosylpropen. J Agric Food Chem. 2008 Jul 9;56(13):5324-30.
6 Chemistry, physiological properties, and microbial production of hydroxycitric acid. Appl Microbiol Biotechnol. 2007 Jul;75(5):977-82.
7 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.
8 Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int. 2009 Jul-Aug;29(4):377-83.